Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
Pierre Dourlen(Inserm), Bart Dermaut(HOGENT University of Applied Sciences and Arts), Francisco-José Fernández-Gómez(Inserm), Philippe Amouyel(Inserm), C. Delay(Inserm), Clément Dupont(Unknown), Nicolas Sergeant(Inserm), Luc Buée(Inserm), Hélène Obriot(Inserm), Céline Bellenguez(Inserm), Julien Chapuis(Inserm), Hilkka Soininen(University of Eastern Finland), Mikko Hiltunen(University of Eastern Finland), Alexis Bretteville(Inserm), Nicolas Malmanche(Universidade do Porto), Raphaëlle Caillierez(Inserm), Yoann Sottejeau(Inserm), Benjamin Grenier‐Boley(University of Bonn), Farida Abdelfettah(Inserm)
Cited by 119
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k